24 results
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Ozempic), or daily tablet ... not definitively cause ... Receptor #Agonists #Pharmacology ... DM2 #diabetes #endocrinology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... failure Common Side Effects ... not definitively cause ... /effect) • Saxagliptin ... DM2 #diabetes #endocrinology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
hypoglycemia risk and effect ... #pharmacology #pharmacotherapy ... #table #comparison ... #management #medications ... #diabetes #endocrinology
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
Indications and Pharmacology ... of Excretion: Urine ... Bleeding Side Effects ... Hypotension with rapid injection ... #Indications #Pharmacology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
kidney), which causes ... glucose in the urine ... Side effects include ... SGLT2 #Inhibitors #Pharmacology ... DM2 #Diabetes #Endocrinology
Diabetes Morning Hyperglycemia - Dawn Phenomenon vs Somogyi Effect 

When patients FBG's are elevated each morning
therapy, it's a good idea ... insulin levels causes ... know about the idea ... Hyperglycemia #Diagnosis #Management ... #Endocrinology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... • In rare cases ... Enteric #Bacterial #IDSA ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Vasopressors Table ... Resistance, Main Uses ... Vasopressors #Properties #Table ... #Pharmacology # ... Effect #Management
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... Clostridium difficile infection ... Episode #Pharmacology ... #Management #CDiff
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... chew, or crush tablet ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology